US 12163153
Methods of manufacturing allogeneic CAR T cells
granted A61KA61K35/17A61K40/11
Quick answer
US patent 12163153 (Methods of manufacturing allogeneic CAR T cells) held by Allogene Therapeutics, Inc. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/17, A61K40/11, A61K40/31, A61K40/4211